• Pregnancy-associated cardiovascular pathology

Pregnancy-associated cardiovascular pathology

PERINATOLOGIYA I PEDIATRIYA. 2016.4(68):19-21; doi 10.15574/PP.2016.68.19 
 

Pregnancy-associated cardiovascular pathology

Limanskaia A. Y., Dvulit M. P., Davydova I. V.

SI «Institute of Pediatrics, Obstetrics and Gynecology of NAMS of Ukraine», Kyiv 
 

In the article was presented the overview of the literature on cardiovascular disease associated with pregnancy. Gestational hypertensive disorders are a pre-dictor of cardiovascular disorders such as: hypertension, coronary heart disease, stroke, heart attack, because they have a similar mechanism of development that is called endothelial dysfunction. In the present day, the presence of hypertension during the pregnancy is considered as an important factor in the prognosis of the development of the cardiovascular disorder in the future life of the woman. All of the aforesaid requires the continuation between obstetrician-gynecologists, cardiologists, general practitioners with the aim of prevention of cardiac disease in the high-risk groups. It needs to be done, also for timely detection and correction of disease that, in turn, will help to reduce morbidity and mortality in women from cardiovascular pathology.


Key words: cardiovascular disease, pregnancy.


References

1. Broun DW, Dueker N. 2006. Preeclampsia and the risk of ischemic stroke among young women. Stroke. 37: 1055—1064. https://doi.org/10.1161/01.STR.0000206284.96739.ee; PMid:16484606

2. Arnadottir GA, Geirsson RT, Arngrimsson R et al. 2005. Cariovascular death in women who had hypertension in pregnancy: a case-control study. BJOG. 112: 286—292. https://doi.org/10.1111/j.1471-0528.2004.00396.x; PMid:15713141

3. Belo L, Caslake M, Gaffney D et al. 2002. Changes in LDL size and HDL concentration in normal and preeclamptic pregnancies. Atherosclerosis. 162(2): 425—532. https://doi.org/10.1016/S0021-9150(01)00734-1

4. Jonsdottir LS, Arngrimsson R, Geirsson RT et al. 1995. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 74(10): 772-776. https://doi.org/10.3109/00016349509021195; PMid:8533558

5. Guidelines for the Management of Arterial Hypertension. 2007. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertension. 25: 1105—1187. PMid:17563527

6. He S, Siveira A, Hamsten A et al. 1999. Haemotstatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia. Thromb Heaemost. 81(4): 538-542. PMid:10235435

7. Hayman R. 2004. Hypertension in pregnancy. Curr Obstet Gynaecol. 14(1): 1—10. https://doi.org/10.1016/j.curobgyn.2003.10.009

8. Wilson B, Watson MS, Prescott GJ et al. 2003. Hypertensive disease of pregnancy and risk of hypertension and stroke in later life: results from cohort study. Br Med J. 326(7394): 845. https://doi.org/10.1136/bmj.326.7394.845

9. Itakura A, Mizutani S. 2005. Involvement of placental peptidases associated with renin-an-giotensin systems in preeclampsia. Biochim Biophys Acta. 1: 1751.

10. Sattar N, Clark P, Greer IA et al. 2000. Lipoprotein (a) levels in normal pregnancy and in pregnancy complicated with pre-eclampsia. Atherpsclerosis. 148(2): 407—411. https://doi.org/10.1016/S0021-9150(99)00296-8

11. Irgens HU, Reisaeter L, Irgens LM, Lie RT. 2001. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. Br Med J. 323(7323): 1213—1217. https://doi.org/10.1136/bmj.323.7323.1213; PMid:11719411 PMCid:PMC59993

12. Ogura K, Miyatake T, Fukui O et al. 2002. Low-density lipoprotein particle diameter in normal pregnancy and preeclampsia. J Atheroscler Thromb. 9(1): 42—47. https://doi.org/10.1016/S1567-5688(08)70164-8https://doi.org/10.5551/jat.9.42; PMid:12238637

13. Bobst SM, Day M-C, Gilstrap LC et al. 2005. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypert. 18(3): 330—336. https://doi.org/10.1016/j.amjhyper.2004.10.002; PMid:15797649

14. Ness R, Marcovic N. 2003. Family history of hypertension, heart disease and stroke among women who develope hypertension in pregnancy. Obstet and Gynecology. 102: 1366—1371. https://doi.org/10.1016/j.obstetgynecol.2003.08.011https://doi.org/10.1097/00006250-200312000-00025; PMid:14662228

15. Naccasha N, Gervasi MT, Chaiworapongsa T et al. 2001. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am J Obstet Gynecol. 185(5): 1118—1123. https://doi.org/10.1067/mob.2001.117682; PMid:11717644

16. Rodie VA, Freeman DJ, Sattar N, Greer IA. 2004. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 175: 189—202. https://doi.org/10.1016/j.atherosclerosis.2004.01.038; PMid:15262174

17. Rodie VA, Freeman DJ, Sattar N, Greer IA. 2004. Preeclampsia and cardiovascular disease: metabolic syndrome of pregnancy? Atherosclerosis. 175: 189—202. https://doi.org/10.1016/j.atherosclerosis.2004.01.038; PMid:15262174

18. Greenwood JP, Scott EM, Stoker JB et al. 2001. Sympathetic neural mechanisms in normal and hypertensive pregnancy in humans. Circulation. 104: 2200—2204. https://doi.org/10.1161/hc4301.098253; PMid:11684631

19. Wilson BJ, Watson MS. 2003. Hypertensive disease of pregnancy and risk of hypertension and stroke in later life; results of cohort study. BMJ. 326: 845—849. https://doi.org/10.1136/bmj.326.7394.845; PMid:12702615 PMCid:PMC153466

20. Working Group Report on High Blood Pressure in Pregnancy. 2001. J Clin Hypertens. 3(2): 75—88.